Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine to reduce postoperative arrhythmia after coronary artery bypass grafting
RBR-556dhrCompleted
- Sponsor
- Santa Casa de Curitiba
- Start
- May 2012
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of colchicine in Atrial fibrillation (AFib) and Chronic Coronary Syndrome (CCS) (2 arms), sponsored by Santa Casa de Curitiba. Primary endpoint: Postoperative arrhythmia reduction. Started May 2012; status: completed.
02
Drugs
colchicine
03
Conditions
Atrial fibrillation (AFib)Chronic Coronary Syndrome (CCS)
Beyond the preview
Go deeper on RBR-556dhr.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-556dhr.